Product development and laboratory acceptability of an Indigenous Therapeutic Food (ITF) for children with Severe Acute Malnutritio
Not Applicable
Not yet recruiting
- Registration Number
- CTRI/2016/12/007587
- Lead Sponsor
- Department of Biotechnology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 11
Inclusion Criteria
Healthy, normal weight children 2 to 5 years of age, free from any disease or acute infection for more than a week
Exclusion Criteria
Children with an acute illness (e.g., fever, diarrhea, acute respiratory tract infection).
Children with severe acute malnutrition.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The mean, standard deviation and the 95% confidence interval (CI) of the mean of the proportion of food consumed in 15 minutes and total time taken to complete consuming the drink will be calculated. If the lower end of the CI is greater than 50%, we will consider the food to be acceptable. The various sensory characteristics that are acceptable will be calculated as percentages of those interviewed.Timepoint: One at the time of recruitment <br/ ><br>
- Secondary Outcome Measures
Name Time Method oneTimepoint: 0
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of Indigenous Therapeutic Foods in treating Severe Acute Malnutrition?
How does the Indigenous Therapeutic Food in CTRI/2016/12/007587 compare to ready-to-use therapeutic foods (RUTF) in SAM treatment outcomes?
Are there specific biomarkers that correlate with improved nutritional recovery in SAM patients using Indigenous Therapeutic Foods?
What adverse events are associated with Indigenous Therapeutic Food formulations in pediatric SAM populations?
What are the key components of the Indigenous Therapeutic Food in CTRI/2016/12/007587 and how do they contribute to its therapeutic profile?